Quick Answer
Apogee Therapeutics, Inc. reported Total Assets of $937.13 million for the year ending 2025.
- Apogee Therapeutics, Inc. showed an increase of +24.3% in Total Assets from 2024 to 2025.
- This data is from Apogee Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2023: $130.67 million | Q3 2023: $426.42 million | Q1 2024: $823.66 million | Q2 2024: $800.66 million | Q3 2024: $776.29 million | Q1 2025: $714.16 million | Q2 2025: $657.77 million | Q3 2025: $626.16 million.
- Over the full 4 years of available data (2022 to 2025), Apogee Therapeutics, Inc.'s Total Assets has grown by 516.3%.
- Historical annual values: Fiscal year 2025: $937.13 million | Fiscal year 2024: $753.95 million | Fiscal year 2023: $401.40 million | Fiscal year 2022: $152.06 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: